John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$230M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$207M |
| 3 |
EA
Electronic Arts
EA
|
+$205M |
| 4 |
Starbucks
SBUX
|
+$171M |
| 5 |
Baidu
BIDU
|
+$159M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$185M |
| 2 |
Elevance Health
ELV
|
+$180M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$169M |
| 4 |
Walt Disney
DIS
|
+$168M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$166M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.51% |
| 2 | Technology | 14.81% |
| 3 | Industrials | 12.21% |
| 4 | Healthcare | 10.11% |
| 5 | Financials | 6.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
PUT
GoPro
GPRO
$112M
| $65K | ﹤0.01% |
15,400
+300
| +2% | +$1.68K |
|
2852
CervoMed
CRVO
$40.1M
| $64K | ﹤0.01% |
+429
| New | +$146K |
|
2853
ICL Group
ICL
$7.28B
| $63K | ﹤0.01% |
11,109
-16,919
| -60% | -$100K |
|
|
AVH
2854
DELISTED
AVIANCA HOLDINGS S.A.
AVH
| $63K | ﹤0.01% |
+15,450
| New | +$78.2K |
|
|
ADIL
2855
Adial Pharmaceuticals
ADIL
$15.3M
| $60K | ﹤0.01% |
+19
| New | +$30.4K |
|
|
DRRX
2856
DELISTED
DURECT Corp
DRRX
| $60K | ﹤0.01% |
12,411
+669
| +6% | +$5.84K |
|
2857
Syndax Pharmaceuticals
SNDX
$1.78B
| $60K | ﹤0.01% |
13,487
-9,578
| -42% | -$52.5K |
|
|
WPRT
2858
Westport Fuel Systems
WPRT
$35M
| $59K | ﹤0.01% |
+4,427
| New | +$100K |
|
|
XIN
2859
DELISTED
Xinyuan Real Estate
XIN
| $59K | ﹤0.01% |
+1,550
| New | +$63.4K |
|
2860
Hallador Energy
HNRG
$771M
| $54K | ﹤0.01% |
10,661
-17,700
| -62% | -$104K |
|
|
ATYR
2861
aTyr Pharma
ATYR
$55.9M
| $54K | ﹤0.01% |
7,728
+315
| +4% | +$2.64K |
|
2862
Cerus
CERS
$548M
| $52K | ﹤0.01% |
10,354
-295,051
| -97% | -$1.71M |
|
|
CFMS
2863
DELISTED
Conformis, Inc. Common Stock
CFMS
| $52K | ﹤0.01% |
5,857
-4,526
| -44% | -$76.1K |
|
|
CSLT
2864
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $51K | ﹤0.01% |
+23,683
| New | +$58.8K |
|
2865
Amtech Systems
ASYS
$249M
| $50K | ﹤0.01% |
+11,100
| New | +$54.2K |
|
2866
X4 Pharmaceuticals
XFOR
$412M
| $50K | ﹤0.01% |
119
-79
| -40% | -$30.1K |
|
|
AAC
2867
DELISTED
AAC Holdings
AAC
| $49K | ﹤0.01% |
+34,819
| New | +$140K |
|
|
FLNT
2868
Fluent
FLNT
$126M
| $48K | ﹤0.01% |
+2,235
| New | +$40.7K |
|
|
RESN
2869
DELISTED
Resonant Inc.
RESN
| $48K | ﹤0.01% |
+35,759
| New | +$87.3K |
|
|
TRIB
2870
Trinity Biotech
TRIB
$7.9M
| $44K | ﹤0.01% |
128
-34
| -21% | -$15.7K |
|
|
OBE
2871
Obsidian Energy
OBE
$735M
| $41K | ﹤0.01% |
14,522
-5,616
| -28% | -$24.9K |
|
|
TRVN
2872
DELISTED
Trevena, Inc.
TRVN
| $41K | ﹤0.01% |
154
-407
| -73% | -$230K |
|
|
LLEX
2873
DELISTED
Lilis Energy, Inc. Common Stock
LLEX
| $40K | ﹤0.01% |
+29,058
| New | +$78.7K |
|
2874
Immunic
IMUX
$224M
| $39K | ﹤0.01% |
522
+156
| +43% | +$18.3K |
|
|
FRTX
2875
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $36K | ﹤0.01% |
98
-34
| -26% | -$13.3K |
|
Similar funds
John Overdeck's Q4 2018 Portfolio in Review
As of Q4 2018, John Overdeck held 3,851 positions worth $25.5B, down 30% from $36.7B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
John Overdeck withdrew a net $5.25B in Q4 2018, closing 943 positions and reducing 1,216 holdings. Its most notable exit was Elevance Health, an estimated $180M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.
Against the trend, John Overdeck opened a new position in Starbucks worth $176M.
- John Overdeck's largest Q4 2018 buy was Starbucks: 2,727,875 shares worth $176M.
- John Overdeck added most to SLB Ltd in Q4 2018, an estimated $230M increase.
- John Overdeck's biggest Q4 2018 reduction was Procter & Gamble, cutting an estimated $185M.
- John Overdeck fully exited Elevance Health in Q4 2018, selling an estimated $180M.
- John Overdeck's ten largest holdings make up 6.8% of its $25.5B portfolio in Q4 2018.
- John Overdeck opened 729 new positions and closed 943 in Q4 2018.
- John Overdeck's portfolio value fell 30% quarter-over-quarter to $25.5B.
Based on Two Sigma Investments's 13F filing for Q4 2018, filed 14 Feb 2019.